Delaware’s COVID-19 vaccination plan is moving into Phase 1B immediately, focusing first on those 65 years old and older, state health officials announced Tuesday. More than 200,000 Delawareans qualify for vaccination in this phase, and ...
WILMINGTON – It’s rare for insurance executives to make the transition to health care, but for Brandon Harvath, it’s a higher calling that led him to change course and eventually lead Saint Francis Healthcare. The ...
WILMINGTON – At the dawn of his presidency, one of the most important victories of Joe Biden’s time as vice president, the Affordable Care Act of 2010, has endured a decade of challenges, funding cuts, ...
By Trinidad Navarro Guest Columnist I am an optimist. I know that we can find sparks of light in even the darkest of times. During COVID-19, belief in a better tomorrow was hard to hold ...
Two major Delaware hospital systems have leapt into an arms race for land acquisition and expansion of services in Sussex County, and it’s likely that trend will continue as retirees continue to flock to rural ...
MILTON — After withdrawing plans to construct a $35 million medical office complex in downtown Milton, developer Phoenix RHCS Holdings has moved the project 3 miles outside town limits with the help of a new ...
By Dr. Bill Chasanov Guest Columnist On Dec. 10, the U.S. Food and Drug Administration’s vaccine advisory panel gave the thumbs up to the Pfizer-BioNTech COVID-19 vaccine. Less than a week later, Beebe administered the ...
GEORGETOWN — Exploring other options to expand in Sussex County, Beebe Healthcare has submitted a notice of intent to build a hybrid freestanding emergency department (FED) between Millsboro and Georgetown. The proposed facility will bring ...
NearForm may not be an easily recognized name in Delaware in the fight against COVID-19, but according to its chief commercial officer Larry Breen that’s nothing new for the company. Headquartered in an Irish seaside ...
WILMINGTON – The pharmaceutical giant AstraZeneca announced Saturday that it has reached an agreement to acquire rare disease specialist Alexion Pharmaceuticals Inc. for $39 billion, the largest industry deal this year, according to officials. The ...
